Es gab 50 kürzliche Insider-Transaktionen für Kintara Therapeutics, Inc. (KTRA), darunter 39 Käufe und 3 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $5.62M und die gesamten Insider-Verkäufe auf RSU Award.
Bedeutende Insider mit kürzlicher Aktivität umfassen Bianco James A., Manuso James S J, Ng George K. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — KTRA
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2024-10-18 |
Bianco James A. |
Chief Executive Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-10-18 |
Bianco James A. |
Chief Executive Officer |
RSU-Zuteilung |
71,560 |
$3.69 |
$264.06K |
71,560 |
| 2024-10-18 |
Manuso James S J |
Director |
Unbekannt |
- |
- |
- |
- |
| 2024-10-18 |
Manuso James S J |
Director |
RSU-Zuteilung |
13,553 |
$4.14 |
$56.11K |
13,553 |
| 2024-10-18 |
Ng George K |
Director |
Unbekannt |
- |
- |
- |
- |
| 2024-10-18 |
Ng George K |
Director |
RSU-Zuteilung |
13,553 |
$4.14 |
$56.11K |
13,553 |
| 2024-10-18 |
List Alan |
Director |
Unbekannt |
- |
- |
- |
- |
| 2024-10-18 |
List Alan |
Director |
RSU-Zuteilung |
13,553 |
$4.14 |
$56.11K |
13,553 |
| 2024-10-18 |
Dearborn Dan |
Chief Financial Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-10-18 |
Dearborn Dan |
Chief Financial Officer |
RSU-Zuteilung |
15,744 |
$3.69 |
$58.1K |
15,744 |
| 2024-10-18 |
Patel Vijay |
10 Percent Owner |
Unbekannt |
1,315,441 |
$5.70 |
$7.5M |
- |
| 2024-10-18 |
Yamashita Dennis |
Chief Scientific Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-10-18 |
Yamashita Dennis |
Chief Scientific Officer |
RSU-Zuteilung |
196,790 |
$3.69 |
$726.16K |
196,790 |
| 2023-08-30 |
Hoffman Robert E. |
President, CEO and Interim CFO |
RSU-Zuteilung |
23,142 |
$4.66 |
$107.73K |
23,142 |
| 2023-08-30 |
Favorito Tamara A |
Director |
RSU-Zuteilung |
8,500 |
$4.66 |
$39.57K |
8,500 |
| 2023-08-30 |
Brown Dennis M |
Chief Scientific Officer |
RSU-Zuteilung |
10,175 |
$4.66 |
$47.36K |
10,175 |
| 2023-08-30 |
Toth Robert Joseph Jr |
Director |
RSU-Zuteilung |
8,500 |
$4.66 |
$39.57K |
8,500 |
| 2023-08-30 |
Johnson Laura L. |
Director |
RSU-Zuteilung |
8,500 |
$4.66 |
$39.57K |
8,500 |
| 2023-06-01 |
Hoffman Robert E. |
President, CEO, and CFO |
RSU-Zuteilung |
59,800 |
- |
- |
68,902 |
| 2023-01-05 |
Brown Dennis M |
Chief Scientific Officer |
Erbschaft (Kauf) |
363 |
- |
- |
5,302 |
| 2022-08-01 |
Hoffman Robert E. |
President and CEO |
RSU-Zuteilung |
1,200,634 |
- |
- |
1,200,634 |
| 2022-08-01 |
Praill Anthony Scott |
Chief Financial Officer |
RSU-Zuteilung |
240,087 |
- |
- |
277,273 |
| 2022-08-01 |
Brown Dennis M |
Chief Scientific Officer |
RSU-Zuteilung |
240,087 |
- |
- |
246,905 |
| 2022-07-01 |
Seymour Tamara A |
Director |
RSU-Zuteilung |
100,000 |
- |
- |
100,000 |
| 2022-07-01 |
Toth Robert Joseph Jr |
Director |
RSU-Zuteilung |
100,000 |
$0.26 |
$25.5K |
100,000 |
| 2022-07-01 |
Johnson Laura L. |
Director |
RSU-Zuteilung |
100,000 |
- |
- |
100,000 |
| 2022-02-15 |
Hoffman Robert E. |
President and CEO |
Informierter Kauf |
55,000 |
$0.47 |
$25.8K |
55,000 |
| 2021-12-08 |
Praill Anthony Scott |
Chief Financial Officer |
Informierter Kauf |
28,700 |
$0.68 |
$19.43K |
37,186 |
| 2021-12-07 |
Zarrabian Saiid |
Head of Strategic Partnerships |
Informierter Kauf |
38,109 |
$0.64 |
$24.3K |
55,500 |
| 2021-12-06 |
Zarrabian Saiid |
Head of Strategic Partnerships |
Informierter Kauf |
11,891 |
$0.59 |
$7.02K |
17,391 |
| 2021-11-22 |
Johnson Laura L. |
Director |
Informierter Kauf |
3,000 |
$0.74 |
$2.23K |
3,000 |
| 2021-11-08 |
Hoffman Robert |
President and CEO |
RSU-Zuteilung |
3,519,170 |
$0.96 |
$3.38M |
3,519,170 |
| 2021-09-22 |
Hoffman Robert |
Director |
RSU-Zuteilung |
100,000 |
$1.24 |
$124K |
100,000 |
| 2021-09-22 |
Seymour Tamara A |
Director |
RSU-Zuteilung |
35,000 |
$1.24 |
$43.4K |
35,000 |
| 2021-09-22 |
Murphy Keith |
Director |
RSU-Zuteilung |
100,000 |
$1.24 |
$124K |
100,000 |
| 2021-09-22 |
Toth Robert Joseph Jr |
Director |
RSU-Zuteilung |
100,000 |
$1.24 |
$124K |
100,000 |
| 2021-09-22 |
Johnson Laura L. |
Director |
RSU-Zuteilung |
100,000 |
$1.24 |
$124K |
100,000 |
| 2021-04-29 |
Praill Anthony Scott |
Chief Financial Officer |
Umwandlung (Verkauf) |
3,750 |
- |
- |
- |
| 2021-04-29 |
Brown Dennis M |
Chief Scientific Officer |
Umwandlung (Verkauf) |
3,000 |
- |
- |
- |
| 2021-04-29 |
Toth Robert Joseph Jr |
Director |
Umwandlung (Verkauf) |
1,300 |
- |
- |
- |
| 2021-04-29 |
Seymour Tamara A |
Director |
Unbekannt |
- |
- |
- |
- |
| 2021-04-29 |
Seymour Tamara A |
Director |
RSU-Zuteilung |
75,000 |
$1.37 |
$102.75K |
75,000 |
| 2021-03-31 |
Praill Anthony Scott |
Chief Financial Officer |
Sonstige (Kauf) |
22 |
- |
- |
7,540 |
| 2021-03-31 |
Brown Dennis M |
Chief Scientific Officer |
Sonstige (Kauf) |
17 |
- |
- |
6,062 |
| 2021-03-31 |
Toth Robert Joseph Jr |
Director |
Sonstige (Kauf) |
8 |
- |
- |
1,238 |
| 2020-12-31 |
Praill Anthony Scott |
Chief Financial Officer |
Sonstige (Kauf) |
22 |
- |
- |
7,518 |
| 2020-12-31 |
Brown Dennis M |
Chief Scientific Officer |
Sonstige (Kauf) |
17 |
- |
- |
6,045 |
| 2020-12-31 |
Toth Robert Joseph Jr |
Director |
Sonstige (Kauf) |
8 |
- |
- |
1,230 |
| 2020-09-30 |
Praill Anthony Scott |
Chief Financial Officer |
Sonstige (Kauf) |
22 |
- |
- |
7,496 |
| 2020-09-30 |
Brown Dennis M |
Chief Scientific Officer |
Sonstige (Kauf) |
17 |
- |
- |
6,028 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
